(ID: 81) Controlled protein release from alginate microparticles: a strategy for enhanced bone regeneration
International Journal of Pharmacy Practice · 05.11.2026 · 34 (Supplement_2) · ii20-ii21
DOI: 10.1093/ijpp/riag145.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 06.11.2026. Verfasst von Fatema Hossam Ragab Mohammad und 4 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Introduction
Bone fractures represent a significant clinical burden, with 5–10% progressing to delayed union or non-union, resulting in prolonged recovery and substantial healthcare costs [1]. Growth factors such as bone morphogenetic proteins (BMPs) can enhance bone regeneration but are limited by rapid degradation, short half-life, and uncontrolled burst release, which may lead to adverse effects [2]. Alginate is a biocompatible polysaccharide that forms ionically crosslinked hydrogels suitable for protein delivery [3]. However, the influence of formulation variables on alginate microparticle physicochemical properties and release behaviour remains insufficiently understood, highlighting the need to optimise these systems for bone regeneration applications.
Aim
To develop and optimise alginate-based microparticles for controlled protein delivery and investigate the effects of bovine serum albumin (BSA) loading, alginate concentration, and calcium chloride (CaCl₂) concentration on microparticle characteristics and release behaviour.
Method
This laboratory-based experimental study was conducted at Ulster University. BSA-loaded alginate microparticles were prepared using ionic gelation. Twenty-eight formulations were prepared by varying BSA concentration (0.25–1.00% w/v), alginate concentration (0.5–2.0% w/v), and CaCl₂ concentration (0.5–2.0% w/v). Particle size, polydispersity index (PDI), and zeta potential were measured using dynamic light scattering. Entrapment efficiency and in vitro release profiles were quantified using high-performance liquid chromatography (HPLC) with UV detection at 280 nm. Release studies were conducted in phosphate-buffered saline (PBS, pH 7.4) at 37 °C over 24 hours under agitation (50 rpm). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey post hoc testing using GraphPad Prism v10, with significance accepted at p < 0.05. Ethical approval was not required as no human participants or patient data were involved.
Results
Entrapment efficiency ranged from 43–58% (n = 3), with significant differences observed between BSA concentrations (p = 0.0109). The highest encapsulation efficiency was achieved at 0.50% w/v BSA. Increasing alginate and CaCl₂ concentrations reduced protein release and produced more sustained release profiles. Protein loading had no significant effect on particle size (p = 0.9269) or final cumulative release (p = 0.2603), although cumulative release increased from 23.6% to 40.7% over 24 hours as BSA concentration increased. The optimised formulation, F7-B0.50 (1.5% w/v alginate, 1% w/v CaCl₂, 0.50% w/v BSA), exhibited a particle size of 762.3 nm, PDI of 0.289, zeta potential of −3.07 mV (n = 3), and 40.7% cumulative release over 24 hours.
Discussion
Alginate and CaCl₂ concentrations were the primary determinants of microparticle structure and release behaviour, whereas protein loading had limited influence on long-term release. Increased polymer concentration and crosslinking density generated denser hydrogel matrices that restricted protein diffusion and prolonged release. An optimal intermediate BSA loading balanced encapsulation efficiency and controlled release. These findings support future growth factor delivery for bone regeneration. Limitations include the use of BSA as a model protein, the 24-hour release period, and the absence of biological evaluation. Future work should evaluate clinically relevant proteins such as BMP-2, investigate longer-term release kinetics, and assess biological activity and therapeutic efficacy in vitro and in vivo to support translational development. Keywords Alginate microparticles, controlled protein release, bone regeneration, drug delivery systems, pharmaceutics
Zitieren
APA
Mohammad, F. H. R., Lennon, L., McGuinness, L., Newman, L., & Lowry, D. (2026). (ID: 81) Controlled protein release from alginate microparticles: a strategy for enhanced bone regeneration. International Journal of Pharmacy Practice, 34(Supplement_2), ii20-ii21. https://doi.org/10.1093/ijpp/riag145.025
Vancouver
Mohammad FHR, Lennon L, McGuinness L, Newman L, Lowry D. (ID: 81) Controlled protein release from alginate microparticles: a strategy for enhanced bone regeneration. International Journal of Pharmacy Practice. 2026;34(Supplement_2):ii20-ii21. doi:10.1093/ijpp/riag145.025
BibTeX
@article{Mohammad2026,
author = {Mohammad, Fatema Hossam Ragab and Lennon, Louis and McGuinness, Laura and Newman, Laura and Lowry, Deborah},
title = {(ID: 81) Controlled protein release from alginate microparticles: a strategy for enhanced bone regeneration},
journal = {International Journal of Pharmacy Practice},
year = {2026},
volume = {34},
number = {Supplement_2},
pages = {ii20--ii21},
doi = {10.1093/ijpp/riag145.025}
}
EUVIMED